CN106754575A
|
|
One streptomyces strain and the method that echinomycin is prepared using the bacterial strain
|
CN106220715A
|
|
A kind of preparation method of bleomycin
|
CN106214674A
|
|
The medical usage of 7 hydroxyl butyphthalides
|
CN106176776A
|
|
The medical usage of glucokinase agonist activity compound
|
CN106035938A
|
|
Lutein ester tableting candy and preparation method thereof
|
CN105669789A
|
|
Preparation method for norvancomycin
|
CN105506041A
|
|
Method for producing norvancomycin by fermentation
|
CN105504024A
|
|
Bacitracin and preparation method of zinc salt thereof
|
CN105566458A
|
|
Method for preparing bacitracin and method for preparing zinc salt of bacitracin
|
CN105483064A
|
|
Method for fermentation production of bacitracin
|
CN105524961A
|
|
Method for producing amphotericin B through fermentation
|
CN105506042A
|
|
Method for producing capreomycin by fermentation
|
CN105504023A
|
|
Capreomycin preparation method
|
CN105267146A
|
|
Preparation method of sterile tacrolimus nano suspension eye drops
|
CN105237599A
|
|
Lipiarmycin A4 crystal and preparation method thereof
|
CN106478659A
|
|
Crystal formation C of benzoxazoles oxazines ketone compounds WA1-089 and preparation method thereof
|
CN106478658A
|
|
Crystal formation D of benzoxazoles oxazines ketone compounds WA1-089 and preparation method thereof
|
CN106478661A
|
|
Crystal formation E of benzoxazoles oxazines ketone compounds WA1-089 and preparation method thereof
|
CN106478660A
|
|
Unformed powder of benzoxazoles oxazines ketone compounds WA1-089 and preparation method thereof
|
CN104892726A
|
|
Method for preparing pristinamycin IIA single component
|